
Precipio PRPO
€ 27.16
3.42%
Geschäftsbericht 2025
hinzugefügt 30.03.2026
Precipio Langfristiger Schuldenstrom 2011-2026 | PRPO
Langfristiger Schuldenstrom Jährlich Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 410 K | 201 K | 218 K | 199 K | 166 K | 225 K | 209 K | 263 K | 587 K | 7.81 M | 7.6 M | 462 K | 242 K | 6.17 M | 3.7 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 7.81 M | 166 K | 1.9 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
662 K | $ 1.63 | -1.21 % | $ 2.17 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 24.7 | -1.12 % | $ 686 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 21.91 | 0.27 % | $ 1.17 B | ||
|
Illumina
ILMN
|
79 M | $ 126.92 | -1.24 % | $ 20.2 B | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 15.3 | -1.92 % | $ 463 M | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 83.55 | -0.67 % | $ 5.64 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 166.79 | -2.59 % | $ 8.27 B | ||
|
National Research Corporation
NRC
|
451 K | $ 16.84 | -1.58 % | $ 377 M | ||
|
Guardant Health
GH
|
27.7 M | $ 83.09 | -6.11 % | $ 10.4 B | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 27.12 | -1.53 % | $ 20 B | ||
|
Personalis
PSNL
|
7.7 M | $ 5.5 | -7.72 % | $ 326 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 1.93 | - | $ 8.54 M | ||
|
Senseonics Holdings
SENS
|
496 K | $ 7.18 | -1.24 % | $ 300 M | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 409.65 | -2.78 % | $ 11.8 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Biomerica
BMRA
|
358 K | $ 2.19 | 0.46 % | $ 5.03 M | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 470.22 | 0.47 % | $ 177 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 102.49 | -0.7 % | $ 8.45 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 259.57 | -1.47 % | $ 21.6 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 9.34 | -1.16 % | $ 2.03 B | ||
|
Celcuity
CELC
|
54 K | $ 120.07 | -4.46 % | $ 5.61 B | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 59.15 | -3.03 % | $ 3.54 B | ||
|
NeoGenomics
NEO
|
4.78 M | $ 9.02 | 4.76 % | $ 1.16 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.84 | 0.21 % | $ 448 M | ||
|
Natera
NTRA
|
7.64 M | $ 200.17 | -2.06 % | $ 19.7 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 195.05 | -0.8 % | $ 21.7 B | ||
|
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | ||
|
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M |